MELANOMA, STAGE II
Clinical trials for MELANOMA, STAGE II explained in plain language.
Never miss a new study
Get alerted when new MELANOMA, STAGE II trials appear
Sign up with your email to follow new studies for MELANOMA, STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New biosimilar aims to match keytruda in melanoma fight
Disease control OngoingThis study compares FYB206, a biosimilar (a very similar copy) of the cancer drug Keytruda, to the original Keytruda in 96 adults with stage IIB/IIC or III melanoma that has been completely removed by surgery. The goal is to see if FYB206 stays in the body the same way as Keytrud…
Matched conditions: MELANOMA, STAGE II
Phase: PHASE1 • Sponsor: Formycon AG • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Melanoma study aims to uncover hidden toll of immunotherapy
Knowledge-focused OngoingThis study looks at side effects and quality of life in people with melanoma who are getting immunotherapy after surgery. Researchers will track symptoms, blood markers, and how patients feel over two years. The goal is to learn more about why some people have side effects and ho…
Matched conditions: MELANOMA, STAGE II
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 03:11 UTC